Every year, tens of thousands of lives are silently stolen by a hidden crisis in India—snakebites. But here's where it gets controversial: while many see this as a tragic yet solvable issue, others argue it's a symptom of deeper systemic failures. Let’s dive into this alarming reality and explore why it’s far more complex than it seems.
Imagine a farmer, Devendra, working in the fields of India, his hands busy picking mulberry leaves. In an instant, a snake strikes, its fangs sinking into his leg. Days later, the pain becomes unbearable, and he rushes to the hospital. Unfortunately, the delay costs him his leg. This story, shared in a short film by the Global Snakebite Taskforce (GST), is just one of countless tales of survival—and loss—in a country where snakebites claim an estimated 50,000 lives annually. Shockingly, this accounts for nearly half of all snakebite deaths worldwide. Some studies suggest the numbers could be even higher, with up to 1.2 million deaths between 2000 and 2019, averaging 58,000 per year.
And this is the part most people miss: the crisis isn’t just about snakes; it’s about a healthcare system struggling to respond. A recent GST report reveals that 99% of healthcare workers in India face significant challenges in administering antivenom, the life-saving treatment for snakebites. Researchers surveyed 904 medical professionals across India, Brazil, Indonesia, and Nigeria—countries hardest hit by snakebites—and found common barriers: poor infrastructure, limited access to antivenom, and inadequate training. Nearly half reported that treatment delays led to severe complications, including amputations, surgeries, or lifelong mobility issues.
Snakebites disproportionately affect poor rural communities in low- and middle-income countries, where access to healthcare is already limited. In India, the central and eastern regions bear the brunt of these tragedies, with farmers and tribal communities at highest risk. Dr. Yogesh Jain, a GST member and practitioner in Chhattisgarh, emphasizes, 'Snakebites are seen as a poor person’s problem, which is why there isn’t enough outrage or action over these completely avoidable deaths.' Every second counts when treating snakebites, as venom can spread rapidly, causing respiratory failure, paralysis, or organ damage.
Yet, delays are common in rural India, where bad roads, distant hospitals, and a lack of ambulances hinder timely treatment. Last September, a pregnant woman in Gujarat died after her family had to carry her 5 kilometers in a cloth sling because no vehicle could reach their remote village. While some states are trying to improve access by stocking antivenom in local health centers, administering it correctly remains a challenge. Many health workers lack proper training and fear adverse reactions in patients, which can be life-threatening.
Here’s where it gets even more complicated: India’s antivenom only protects against the 'big four' snakes—the spectacled cobra, common krait, Russell’s viper, and saw-scaled viper. But dozens of other venomous species, like the green pit viper and Malabar pit viper, lack targeted treatments. A 2023 study by AIIMS Jodhpur found that two-thirds of patients treated with antivenom for unknown snake species did not respond well, highlighting the urgent need for region-specific antivenom.
Organizations like The Liana Trust are working to develop antidotes for lesser-known species, but progress is slow due to the labor-intensive process. Gerry Martin, co-founder of The Liana Trust, calls for states to follow Karnataka’s lead in making snakebites a notifiable disease, ensuring better reporting and response. Dr. Jain adds, 'Snakebite deaths start where political will ends. Governments must ensure poor people don’t get poor health systems. They deserve better.'
India’s 2024 National Action Plan for Prevention and Control of Snakebite Envenoming (NAPSE) aims to halve snakebite deaths by 2030 through improved surveillance, antivenom availability, medical training, and public awareness. While experts applaud the initiative, inconsistent implementation raises concerns. Is this plan enough, or does it merely scratch the surface of a deeper issue?
What do you think? Is India’s snakebite crisis a matter of resources, awareness, or political priority? Share your thoughts in the comments—let’s spark a conversation that could save lives.
